Stay updated on Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial
Sign up to get notified when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.

Latest updates to the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page
- Check7 days agoChange DetectedThe web page now includes a service alert about planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.4 to v2.16.5.SummaryDifference1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check42 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check50 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check78 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
Stay in the know with updates to Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Injectable Cabotegravir vs TDF/FTC in MSM Clinical Trial page.